Fresenius SE & Co. KGaA · XETR:FRE
Fresenius SE & Co. KGaA — Shareholder Meeting (August 2020)
35 slides from Fresenius SE & Co. KGaA's shareholder meeting presentation, Aug 28, 2020
Slide 1: Annual General Meeting – Fresenius SE & Co. KGaA
Annual General Meeting – Fresenius SE & Co. KGaA August 28, 2020 Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA
Slide 2: Welcome!
Welcome! Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 2
Slide 3: In battle against the coronavirus
In battle against the coronavirus Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 3
Slide 4: Acute care hospitals: a focal point
Acute care hospitals: a focal point Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 4
Slide 5: Ensuring dialysis continues during the pandemic
Ensuring dialysis continues during the pandemic Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 5
Slide 6: Maintaining the production and distribution of life-sustaining products
Maintaining the production and distribution of life-sustaining products Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 6
Slide 7: A consistent shift to Mobile Work
A consistent shift to Mobile Work Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 7
Slide 8: Accelerating digitalization across the board
Accelerating digitalization across the board Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 8
Slide 9: Putting even more “we” in Fresenius
Putting even more “we” in Fresenius Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 9
Slide 10: Solid business development despite the pandemic
Solid business development despite the pandemic Sales EBIT Net income in €m +5% -1% -6% 18,055 2,248 2,248 17,256 928 875 H1/2019 H1/2020 H1/2019 H1/2020 H1/2019 H1/2020 Constant currency growth rates; EBIT and net income before special items Annual General Meeting | August 28, 2020 | © Fresenius SE
Slide 11: Pandemic puts pressure on share price
Pandemic puts pressure on share price 55 50 45 40 35 30 25 Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 11
Slide 12: Learning the right lessons
Learning the right lessons Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 12
Slide 13: Solidarity, not selfishness
Solidarity, not selfishness Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 13
Slide 14: 2019: A year of investment
2019: A year of investment Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 14
Slide 15: 16th consecutive record year
16th consecutive record year Sales (in €bn) Net income (in €m) 35.5 1,915 1,872 32.8 33.0 1,804 29.5 28.0 1,560 1,436 23.5 20.5 1,088 19.5 1,028 944 16.0 16.5 14.2 758 12.4 657 10.8 11.4 496 7.3 7.9 422 437 7.1 330 222 166 115 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 201
Slide 16: 27th consecutive dividend increase proposed
27th consecutive dividend increase proposed 0.84 0.80 0.75 15% 0.62 CAGR 0.55 0.44 0.42 € 0.37 0.32 0.29 0.25 0.23 0.22 0.19 0.02 1993 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2019: Proposal Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 16
Slide 17: Expanding and advancing home dialysis
Expanding and advancing home dialysis Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 17
Slide 18: New dialysis machine for emerging markets
New dialysis machine for emerging markets Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 18
Slide 19: First biosimilar launched
First biosimilar launched Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 19
Slide 20: Investments in production facilities
Investments in production facilities Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 20
Slide 21: Challenges in Germany
Challenges in Germany Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 21
Slide 22: New business models
New business models Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 22
Slide 23: Digitalization in the hospitals
Digitalization in the hospitals Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 23
Slide 24: Acquisition of Malteser hospitals in Germany
Acquisition of Malteser hospitals in Germany Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 24
Slide 25: Acquisition of hospital in Albacete, Spain
Acquisition of hospital in Albacete, Spain Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 25
Slide 26: New proton beam therapy center in Madrid
New proton beam therapy center in Madrid Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 26
Slide 27: Additional acquisitions in Colombia
Additional acquisitions in Colombia Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 27
Slide 28: Leading provider of post-acute care
Leading provider of post-acute care Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 28
Slide 29: Milestone in project business
Milestone in project business Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 29
Slide 30: Superbly positioned for continued growth
Superbly positioned for continued growth Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 30
Slide 31: 2020 guidance revised to include COVID-19 effects
2020 guidance revised to include COVID-19 effects +3 to +6% Sales growth constant currency -4 to +1% Net income growth constant currency Before special items, incl. estimated Covid-19-effects Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 31
Slide 32: Medium-term goals for 2020-2023 confirmed
Medium-term goals for 2020-2023 confirmed +4 to +7% Average annual sales growth organic +5 to +9% Average annual earnings growth organic plus ~1% small to mid-size acquisitions Before special items Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 32
Slide 33: Anchoring sustainability even more firmly in Fresenius
Anchoring sustainability even more firmly in Fresenius Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 33
Slide 34: Our commitment: Ever better medicine for ever more people
Our commitment: Ever better medicine for ever more people Annual General Meeting | August 28, 2020 | © Fresenius SE & Co. KGaA 34
Slide 35: Safe Harbor Statement
Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive
Fresenius SE & Co. KGaA — Shareholder Meeting (August 2020) on 6ix